First Hospital Of China Medical University

This study tests a two-drug combination (sacituzumab govitecan and tislelizumab) given before surgery to people with early-stage triple-negative breast cancer. The goal is to see if this treatment can shrink tumors enough to allow a less aggressive approach, based on specific mar…

This study tests whether a clot-dissolving drug called tenecteplase works better than standard antiplatelet pills for people who have had a mild but disabling stroke caused by a large blocked artery. The treatment is given 4.5 to 24 hours after symptoms start. About 864 adults wi…

This study tests a combination of three treatments—FOLFOX-HAIC (chemotherapy directly into the liver), lenvatinib (a targeted drug), and tislelizumab (an immunotherapy)—in 38 adults with advanced liver cancer that has spread into the main portal vein. The goal is to shrink the tu…

This study tests whether an AI-powered tool can help community doctors improve control of high blood pressure, diabetes, and high cholesterol in 6,800 adults. Participants will be randomly assigned to either AI-assisted care or usual care. The goal is to see if the AI helps more …

This study tests a new drug called SHR-A1811, given alone or with hormone therapy (letrozole), before surgery for early-stage breast cancer that is hormone-receptor-positive and HER2-low. About 120 women will be randomly assigned to one of three groups: the new drug plus hormone …

This study aims to improve early detection of Alzheimer's disease by combining digital tools (like gait and speech analysis) with blood tests. Researchers will screen 1,000 adults aged 50 and older in communities to see if this approach is more efficient than traditional methods.…

This study will use artificial intelligence and 3D ultrasound to measure how well the right side of the heart works together in healthy adults and people with certain heart conditions. Researchers will enroll about 2,640 participants to establish normal values and see if these me…

This study aims to improve how doctors predict which heart failure patients will respond to cardiac resynchronization therapy (CRT), a special pacemaker. Researchers will use a new imaging technique called myocardial work to measure heart function in over 3,000 healthy adults and…